Retained Earnings (Accumulated Deficit) of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Universe Pharmaceuticals INC quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
Universe Pharmaceuticals INC Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $13,843,623.
Source SEC data: View on sec.gov

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Universe Pharmaceuticals INC Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$13,843,623	+$10,157,724,377		30 Sep 2025	20-F	29 Jan 2026	2025	FY
Q3 2024	$10,171,568,000^*	-$10,170,123,730		30 Sep 2024	20-F	29 Jan 2026	2025	FY
Q1 2024	$2,942,153	-$18,549,091	-119%	31 Mar 2024	6-K	20 Sep 2024	2024	Q2
Q3 2023	$1,444,270	-$17,766,635	-109%	30 Sep 2023	20-F	29 Apr 2025	2024	FY
Q1 2023	$15,606,938	-$11,183,728	-42%	31 Mar 2023	6-K	31 Aug 2023	2023	Q2
Q3 2022	$16,322,365	-$8,736,566	-35%	30 Sep 2022	20-F	30 Jan 2024	2023	FY
Q1 2022	$26,790,666			31 Mar 2022	6-K	16 Aug 2022
Q3 2021	$25,058,931	+$11,319,952	+82%	30 Sep 2021	20-F	10 Feb 2023	2022	FY
Q3 2020	$13,738,979			30 Sep 2020	20-F	31 Jan 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.